Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Julia Illmer
Observed names:
J. Illmer,
Julia I. Hummel
Institutions:
University of Salzburg,
Paracelsus Medical University,
EB House Austria
Observed institutions:
University of Salzburg,
Paracelsus Medical University,
EB House Austria
ORCID:
0000-0002-8305-6135
Observed ORCID:
0000-0002-8305-6135
OpenAlex ID:
A5073020196
A non-viral and selection-free COL7A1 HDR approach with improved safety profile for dystrophic epidermolysis bullosa
2021
·
Thomas Kocher
, Johannes Bischof
, et al.
·
Molecular Therapy — Nucleic Acids
·
28
Personalized Development of Antisense Oligonucleotides for Exon Skipping Restores Type XVII Collagen Expression in Junctional Epidermolysis Bullosa
2021
·
Michael Ablinger
, Thomas Lettner
, et al.
·
International Journal of Molecular Sciences
·
26
PDF
Paired nicking-mediated COL17A1 reframing for junctional epidermolysis bullosa
2022
·
Johannes Bischof
, Oliver Patrick March
, et al.
·
Molecular Therapy
·
23
PDF
Biomarker Discovery in Rare Malignancies: Development of a miRNA Signature for RDEB-cSCC
2023
·
Roland Zauner
, Monika Wimmer
, et al.
·
Cancers
·
9
PDF
HMCN1 variants aggravate epidermolysis bullosa simplex phenotype
2025
·
Shir Bergson
, Ofer Sarig
, et al.
·
The Journal of Experimental Medicine
·
7
MicroRNA-200b-mediated reversion of a spectrum of epithelial-to-mesenchymal transition states in recessive dystrophic epidermolysis bullosa squamous cell carcinomas
2023
·
Julia Illmer
, Roland Zauner
, et al.
·
British Journal of Dermatology
·
7
PDF
Repurposing diacerein for the treatment of chronic wounds in recessive‐dystrophic epidermolysis bullosa patients by modulating matrix metalloproteinase‐9 expression
2025
·
Sonja Dorfer
, Michael Ablinger
, et al.
·
The Journal of Dermatology
·
6
PDF
Keratin-associated epidermolysis bullosa simplex: phenotypes and challenges in clinical trials – a narrative review and systematic update
2025
·
Verena Wally
, Tobias Welponer
, et al.
·
Orphanet Journal of Rare Diseases
·
4
PDF
Transcriptome-guided drug repurposing identifies selumetinib for an aggressive epithelial cancer
2025
·
Sonja Dorfer
, Roland Zauner
, et al.
·
Journal of Investigative Dermatology
·
1
382 Selumetinib, identified by transcriptome-guided drug repurposing, targets highly aggressive RDEB-SCCs
2024
·
S. Dorfer
, R. Zauner
, et al.
·
Journal of Investigative Dermatology
PDF
181 Investigating the potential of repurposing diacerein for the treatment of cutaneous wounds in recessive dystrophic epidermolysis bullosa
2023
·
S. Dorfer
, M. Ablinger
, et al.
·
Journal of Investigative Dermatology
PDF
ISID0842 - Methylome profiling identifies recessive dystrophic epidermolysis bullosa-specific epigenetic patterns in keratinocytes
2023
·
Julia Illmer
842 Methylome profiling identifies recessive dystrophic epidermolysis bullosa-specific epigenetic patterns in keratinocytes
2023
·
J. Illmer
, M. Wimmer
, et al.
·
Journal of Investigative Dermatology
PDF
853 HMCN1 variants aggravate epidermolysis bullosa phenotype
2023
·
S. Bergson
, O. Sarig
, et al.
·
Journal of Investigative Dermatology
PDF
476 Differential regulation of miR-200b in squamous cell carcinoma of patients with recessive dystrophic epidermolysis bullosa
2022
·
J. Illmer
, M. Wimmer
, et al.
·
Journal of Investigative Dermatology
PDF
ESDR476 - Differential regulation of miR-200b in squamous cell carcinoma of patients with recessive dystrophic epidermolysis bullosa
2022
·
Julia Illmer
, Monika Wimmer
, et al.
Show more works
View as search
Works count:
16
Citation count:
111
H-index:
6
I10-index:
3
Year
Topic
Type